Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hair-cycle changes in two patients taking tocilizumab.
Vidon C, Bossert M, Lohse-Walliser A, Godfrin-Valnet M, Balblanc JC, Wendling D. Vidon C, et al. Among authors: balblanc jc. Joint Bone Spine. 2014 Jan;81(1):100-1. doi: 10.1016/j.jbspin.2013.07.002. Epub 2013 Aug 13. Joint Bone Spine. 2014. PMID: 23953226 No abstract available.
Aortic involvement in giant cell arteritis: current data.
Bossert M, Prati C, Balblanc JC, Lohse A, Wendling D. Bossert M, et al. Among authors: balblanc jc. Joint Bone Spine. 2011 May;78(3):246-51. doi: 10.1016/j.jbspin.2010.09.013. Epub 2010 Oct 27. Joint Bone Spine. 2011. PMID: 21030278 Review.
Standardized Follow-up of Patients with Symptomatic Knee Osteoarthritis Treated with a Single Intra-articular Injection of a Combination of Cross-Linked Hyaluronic Acid and Mannitol.
Conrozier T, Bozgan AM, Bossert M, Sondag M, Lohse-Walliser A, Balblanc JC. Conrozier T, et al. Among authors: balblanc jc. Clin Med Insights Arthritis Musculoskelet Disord. 2016 Sep 25;9:175-9. doi: 10.4137/CMAMD.S39432. eCollection 2016. Clin Med Insights Arthritis Musculoskelet Disord. 2016. PMID: 27688712 Free PMC article.
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.
Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, Bozgan AM, Gendrin V, Charpentier A, Toko L, Badie J, Mezher C, Roux MF, Kadiane-Oussou NJ, Contreras R, Kessler J, Mazurier I, Klopfenstein T, Zayet S. Conrozier T, et al. Among authors: balblanc jc. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):742-747. Epub 2020 Jun 23. Clin Exp Rheumatol. 2020. PMID: 32573419 Free article.
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19).
Lohse A, Klopfenstein T, Balblanc JC, Royer PY, Bossert M, Gendrin V, Charpentier A, Bozgan AM, Badie J, Bourgoin C, Contreras R, Mazurier I, Conrozier T, Zayet S. Lohse A, et al. Among authors: balblanc jc. Microbes Infect. 2020 Oct;22(9):500-503. doi: 10.1016/j.micinf.2020.06.005. Epub 2020 Jun 20. Microbes Infect. 2020. PMID: 32574789 Free PMC article.
45 results